Captor Therapeutics S.A. (CTX) — Financial Flexibility Index
Captor Therapeutics S.A. (CTX) has a Financial Flexibility Index of -1.02x as of September 2025. Free cash flow of zł-11.51 Million (operating CF zł-11.51 Million minus capex zł0.00) represents -1% of total liabilities (zł11.27 Million). Check Captor Therapeutics S.A. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Captor Therapeutics S.A. Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Captor Therapeutics S.A. across 8 annual periods. See Captor Therapeutics S.A. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Captor Therapeutics S.A. (2017–2024)
Year-by-year free cash flow to debt coverage for Captor Therapeutics S.A.. For the full company profile including market capitalisation, see Captor Therapeutics S.A. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.37x | zł-31.45 Million | zł-31.88 Million | zł23.02 Million | ▲ +22.0% |
| 2023 | -1.75x | zł-49.20 Million | zł-52.20 Million | zł28.07 Million | ▼ -32.5% |
| 2022 | -1.32x | zł-22.06 Million | zł-22.95 Million | zł16.68 Million | ▼ -9.5% |
| 2021 | -1.21x | zł-23.36 Million | zł-28.47 Million | zł19.34 Million | ▼ -8346.5% |
| 2020 | -0.01x | zł-383.00K | zł-595.00K | zł26.78 Million | ▼ -106.5% |
| 2019 | 0.22x | zł4.62 Million | zł4.39 Million | zł21.02 Million | ▲ +258.5% |
| 2018 | -0.14x | zł-2.03 Million | zł-2.13 Million | zł14.63 Million | ▼ -133.0% |
| 2017 | 0.42x | zł2.10 Million | zł2.10 Million | zł4.98 Million | — |